Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/222092
Title: Long COVID in ARDS Survivors: Insights from a Two-Year-Follow-Up Study After the First Wave of the Pandemic
Author: Aranda, Judit
Oriol, Isabel
Vázquez Bellón, Núria
Ramos, Karim
Suárez, Romina Concepcion
Feria, Lucía
Peñafiel, Judith
Coloma, Ana
Borjabad, Beatriz
Cliville, Raquel
Vacas, Montserrat
Carratalà, Jordi
Keywords: COVID-19
Pandèmia de COVID-19, 2020-2023
Síndrome del destret respiratori de l'adult
COVID-19
COVID-19 Pandemic, 2020- 2023
Adult respiratory distress syndrome
Issue Date: 10-Mar-2025
Publisher: MDPI
Abstract: Objectives: To compare the health status, exercise capacity, and health-related quality of life (HRQoL) in survivors of COVID-19-associated acute respiratory distress syndrome (ARDS) at 8, 12, and 24 months post-diagnosis. Methods: We conducted a prospective, single-center follow-up study embedded within a larger multicenter cohort of adults with COVID-19 who required hospital admission. Eligible participants underwent clinical interviews, physical examinations, chest radiography, and the 6-min walk test (6MWT). Standardized scales were used to assess post-traumatic stress disorder (PTSD), anxiety, depression, and HRQoL. Results: Out of 1295 patients with COVID-19, 365 developed ARDS, of whom 166 survived. After excluding deaths and loss to follow-up, 95 patients were monitored for 24 months. Over 60% of patients had persistent symptoms, though significant improvements were recorded in quality of life and physical recovery. More than 70% recovered their previous physical capacity, but 15% did not return to their usual lifestyle habits. Symptoms such as arthralgia and fatigue decreased, but cognitive issues, such as memory loss and insomnia, persisted. Radiological improvements were noted, although pulmonary function remained impaired. The prevalence of PTSD and anxiety decreased, while depression remained stable at around 30%. Conclusions: Long COVID continues to impose significant physical, mental, and social challenges. Symptoms like fatigue and anxiety have a profound impact on daily life. Strategies are urgently needed to help patients regain health and resume their normal lives.
Note: Reproducció del document publicat a: https://doi.org/10.3390/jcm14061852
It is part of: Journal of Clinical Medicine, 2025, vol. 14, num. 6, 1852
URI: https://hdl.handle.net/2445/222092
Related resource: https://doi.org/10.3390/jcm14061852
ISSN: 2077-0383
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
jcm-14-01852-v2.pdf2.29 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons